✦ LIBER ✦

Graft-versus-host disease following second syngeneic stem cell transplantation for relapsed chronic myeloid leukemia

✍ Scribed by E. Reiter; H. T. Greinix; G. Mitterbauer; G. Fischer; F. Keil; C. Mannhalter; W. Rabitsch; I. Schwarzinger; N. Worel; K. Lechner; P. Kalhs

Publisher: Springer
Year: 1998
Tongue: English
Weight: 117 KB
Volume: 77
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s002770050459

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Graft-versus-Host Disease, the Graft-ver

Graft-versus-Host Disease, the Graft-versus-Leukemia Effect, and Mixed Chimerism following Nonmyeloablative Stem Cell Transplantation

✍ Shimon Slavin 📂 Article 📅 2003 🏛 Carden Jennings Publishing 🌐 English ⚖ 160 KB

Gastrointestinal relapse of leukemia, mi

Gastrointestinal relapse of leukemia, mimicking acute graft vs. host disease, following a stem cell transplant

✍ Kletzel, Morris; Meitar, Dafna; El-Youssef, Mounif; Cohn, Susan L. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 515 KB

Chronic Graft-versus-Host Disease follow

Chronic Graft-versus-Host Disease following Varicella-Zoster Virus Infection in Allogeneic Stem Cell Transplant Recipients

✍ Noriaki Kawano; Hisashi Gondo; Tomohiko Kamimura; Kenichi Aoki; Tadafumi Iino; F 📂 Article 📅 2003 🏛 Carden Jennings Publishing 🌐 English ⚖ 108 KB

Filgrastim Treatment of Acute Myelogenou

Filgrastim Treatment of Acute Myelogenous Leukemia (M7) Relapse after Allogeneic Peripheral Stem Cell Transplantation Resulting in Both Graft-versus-Leukemia Effect with Cytogenetic Remission and Chronic Graft-versus-Host Disease Manifesting as Polyserositis and Subsequent Bronchiolitis Obliterans with Organizing Pneumonia

✍ L. Law; J. Tuscano; T. Wun; K. Ahlberg; C. Richman 📂 Article 📅 2002 🏛 Carden Jennings Publishing 🌐 English ⚖ 97 KB

Recombinant human soluble tumor necrosis

Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

✍ Alessandro Busca; Franco Locatelli; Filippo Marmont; Cristina Ceretto; Michele F 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 2 views

## Abstract Etanercept is a recombinant human soluble tumor necrosis factor (TNF‐α) receptor fusion protein that inhibits TNF‐α, a major mediator in the pathogenesis of graft‐versus‐host disease (GVHD). The purpose of our study was to evaluate the safety and efficacy of etanercept therapy in 21 pat

Liver function tests and absolute lympho

Liver function tests and absolute lymphocyte count at day +100 are predictive factors for extensive and severe chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplant

✍ Fernando Silva; José A. Pérez-Simón; Teresa Caballero Velazquez; Cristina Encina 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 705 KB

The 2009 American Society of Hematology (ASH) annual meeting introduced novel strategies for the treatment of acute leukemia. Targeted inhibitors for both acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) represent the future of these malignancies. Inclusion of targeted treatment t